CorMedix Inc. (CRMD) vs CytomX Therapeutics, Inc. (CTMX)

A side-by-side comparison of CorMedix Inc. and CytomX Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRMD vs CTMX

growth of $100 · dividends reinvested · last 10y
CRMD -48.3% (-6.4%/yr)CTMX -83.1% (-16.3%/yr)CRMD compounded faster over this window
050100150200Start $10020182020202220242026$52$17
CRMD CTMX

CRMD vs CTMX: by the numbers

  • •CRMD is the larger company ($564M vs $554M market cap).
  • •CRMD is profitable (40.49% net margin) while CTMX runs a net loss (-435.21%).
  • •CRMD grew revenue faster over the past five years (352.03% vs 2.18% CAGR).

Metrics side by side

Valuation

MetricCRMDCTMX
P/E ratio3.37N/A
Forward P/E14.52N/A
P/S ratio1.2230.25
P/B ratio1.221.83
EV / EBITDA1.79N/A
FCF yield44.38%N/A

Profitability

MetricCRMDCTMX
Gross margin82.78%98.63%
Operating margin46.95%-29.35%
Net margin40.49%-435.21%
ROE40.62%-26.37%
ROIC27.87%-25.42%

Growth (annualized)

MetricCRMDCTMX
Revenue CAGR (5Y)352.03%2.18%
Total return CAGR (5Y)9.70%-12.01%

Frequently asked

Which has grown faster, CRMD or CTMX?
Over the past five years, CRMD grew revenue faster — CRMD at a 352.03% CAGR versus CTMX at 2.18%.
Is CRMD or CTMX more profitable?
CRMD runs the higher net margin — CRMD at 40.49% versus CTMX at -435.21%.
How have CRMD and CTMX total returns compared?
Over the past 10 years, CRMD delivered -7.74% and CTMX delivered -16.62% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.